Inactive Instrument
Monto Minerals Ltd Stock Australian S.E.
Stocks
AU000000MOO0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - AUD | - |
|
| 05-10 | Pathkey.AI appoints Andrew Farnsworth as CEO | RE |
| 04-28 | Pathkey.AI to acquire AI semiconductor design verification platform | RE |
| Market Cap | 43.1M 29.76M 26.09M 24.05M 22.52M 42.23M 2.81B 289M 112M 1.39B 112M 109M 4.81B | P/E 2024 |
-1.36x | P/E 2025 | -3.77x |
|---|---|---|---|---|---|
| Enterprise Value | 43.08M 29.74M 26.08M 24.04M 22.51M 42.2M 2.81B 289M 112M 1.39B 112M 109M 4.81B | EV / Sales 2024 |
9.78x | EV / Sales 2025 | 21.1x |
| Free-Float |
59.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 22-07-28 | Opyl : Business Update & Appendix 4C | PU |
| 22-04-27 | Opyl : Business Update & Appendix 4C | PU |
| 22-02-27 | Opyl : Appendix 4D & Half Year Results | PU |
| 21-12-14 | Opyl : 2021 Annual Report to shareholders | PU |
| 21-11-17 | Opyl : 2021 AGM Presentation 18 November 2021 | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Angelone
CTO | Chief Tech/Sci/R&D Officer | - | 1994-01-16 |
| Chief Executive Officer | - | 2026-05-10 | |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Damon Rasheed
CHM | Chairman | - | 2025-10-20 |
Paul Niardone
BRD | Director/Board Member | - | 2025-10-20 |
Shannon Robinson
CHM | Chairman | - | 2025-11-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.40% | +11.78% | -39.54% | -15.04% | 27.84B | ||
| +1.88% | +9.31% | -32.68% | +189.21% | 13.62B | ||
| -1.01% | -1.08% | -20.41% | +57.72% | 5.43B | ||
| +1.92% | +5.98% | - | - | 3.07B | ||
| +0.30% | +13.66% | - | - | 2.11B | ||
| +1.52% | +2.77% | +36.59% | -41.96% | 1.83B | ||
| -1.43% | -7.17% | -31.18% | - | 1.22B | ||
| +1.84% | +0.87% | -35.74% | +246.20% | 740M | ||
| -1.55% | +29.80% | +606.67% | +863.64% | 726M | ||
| Average | +1.32% | +7.15% | +69.10% | +216.63% | 6.29B | |
| Weighted average by Cap. | +4.63% | +9.05% | -23.62% | +63.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 398K 275K 241K 222K 208K 390K 25.9M 2.67M 1.03M 12.8M 1.03M 1.01M 44.38M | 322K 222K 195K 180K 168K 315K 20.97M 2.16M 836K 10.37M 835K 817K 35.94M |
| Net income | -3.13M -2.16M -1.9M -1.75M -1.64M -3.07M -204M -21M -8.12M -101M -8.12M -7.94M -349M | -1.45M -1M -876K -808K -756K -1.42M -94.3M -9.71M -3.76M -46.6M -3.75M -3.67M -162M |
| Net Debt | -375K -259K -227K -209K -196K -367K -24.4M -2.51M -972K -12.06M -971K -950K -41.82M | -25.17K -17.38K -15.24K -14.04K -13.15K -24.65K -1.64M -169K -65.31K -810K -65.25K -63.82K -2.81M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















